LIGAND PHARMACEUTICALS INCORPORATED Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $352.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2026-08-07
- 2026-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $352.00K.
- 2026-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $352.00K.
- 2025-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $395.00K.
- 2025-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $390.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value as first filed |
|---|---|---|
| 2026-06-30 | $352.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $352.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $395.00K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $390.00K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $351.00K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $388.00K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $383.00K 10-K · filed 2026-02-27 | |
| 2024-09-30 | $223.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $264.00K 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $218.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $320.00K 10-K · filed 2026-02-27 | |
| 2022-12-31 | $84.00K 10-K · filed 2025-02-28 | |
| 2021-12-31 | $349.00K 10-K · filed 2024-02-29 | |
| 2018-12-31 | $6.99M 10-K · filed 2019-02-28 | |
| 2017-12-31 | $9.99M 10-K · filed 2019-02-28 | |
| 2016-12-31 | $1.60M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $6.71M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $6.97M 10-Q · filed 2016-11-14 | |
| 2016-03-31 | $6.86M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $9.49M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $10.49M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $10.37M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $9.50M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $11.82M 10-K · filed 2016-11-14 | $21.06M 10-K · filed 2014-12-01 |
| 2014-09-30 | $13.46M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $11.18M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $8.32M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $21.06M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $22.13M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $21.03M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $25.30M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $23.65M 10-K/A · filed 2014-12-12 | $23.43M 10-K · filed 2013-03-14 |
| 2011-12-31 | $37.68M 10-K · filed 2013-03-14 | |
| 2010-12-31 | $31.59M 10-K · filed 2013-03-14 |